Lung Cancer in a Male Smoker Treated by Adjunct Nutritional and Phyto-Therapy
Keywords:Non-small cell lung cancer, angiogenesis, metastasis, cachexia, anorexia, nutritional therapy, CT scans and chest X-rays, adjunct cancer therapy
Current understanding of the aetiology of lung cancer suggests that oxidative stress is strongly implicated in its pathogenesis with both internal cellular production of free radicals and external carcinogens such as from tobacco smoke. Other risk factors include family history, exposure to radiation, chronic obstructive pulmonary disease, overweight, chronic inflammation, and poor dietary habits. Patient's survival rates have not changed appreciably suggesting that Western conventional therapeutic advances have been rather slow. This case study shows how a well-designed nutritional and phyto-therapy may offer an effective adjunct treatment for non-small cell lung cancer (NSCLC). The protocol included dietary and lifestyle modifications as well as the use of evidence-based nutraceuticals and herbs. The terminal cancer patient in question was diagnosed by his oncologist as being cancer-free after five months or so. According to ANMP (www.anmp.org.my), such a protocol treats, controls, and/or prevents chronic metabolic disorders such as cancer by impacting on the patient's physiological, hormonal, and/or immune functions.
Goodman M. Vegetable consumption in lung cancer longevity. Eur J Cancer 1992; 28: 495-9. http://dx.doi.org/10.1016/S0959-8049(05)80086-3
Tang NP, Zhou B, Wang B, Yu RB, Ma J. Flavonoids intake and risk of lung cancer: a meta-analysis. Jpn J Clin Oncol 2009; 39: 352-9. http://dx.doi.org/10.1093/jjco/hyp028
Gaby A. Nutritional Medicine. Fritz Perlbery Publishing. Concord NH: 2011; P1212.
Schabath MB, Hernandez LM, Wu X, Pillow PC, Spitz MR. Dietary phytoestrogens and lung cancer risk. JAMA 2005; 294: 1493-504. http://dx.doi.org/10.1001/jama.294.12.1493
Sommerburg O, Keunen JE, Bird AC, van Kuijk FJ. Fruits and vegetables that are sources for lutein and zeaxanthin: the macular pigment in human eyes. Br J Ophthalmol1998; 82: 907-10.http://dx.doi.org/10.1136/bjo.82.8.907
Pung A, Rundhaug JE, Yoshizawa CN, Bertram JS. Beta carotene and canthaxanthin inhibit chemically and physically induced neoplastic transformation in 10T1/2 cells. Carcinogenesis1988; 9: 1533-9. http://dx.doi.org/10.1093/carcin/9.9.1533
Heimburger D. Localized deficiencies of folic acid in aerodigestive tissues. Ann NY Acad Sci 1992; 669: 87-96. http://dx.doi.org/10.1111/j.1749-6632.1992.tb17091.x
Sun Y. Free radicals, antioxidant enzymes, and carcinogenesis. Free Radic Biol Med 1990; 8: 583-99. http://dx.doi.org/10.1016/0891-5849(90)90156-D
Borek C. Free-radical processes in multistage carcinogenesis. Free Radic Res Commun 1991; 12-13(Pt 2): 745-50. http://dx.doi.org/10.3109/10715769109145854
Florence TM. The role of free radicals in disease. Aust NZ J Ophthalmol 1995; 23: 3-7. http://dx.doi.org/10.1111/j.1442-9071.1995.tb01638.x
Chen J, Geissler C, Parpia B, Li J, Campbell TC.Antioxidant status and cancer mortality in China.Int J Epidemiol 1992; 21: 625-35. http://dx.doi.org/10.1093/ije/21.4.625
Stahelin HB, Gey KF, Eichholzer M, Lüdin E, Bernasconi F, et al.Plasma antioxidant vitamins and subsequent cancer mortality in the 12-year follow-up of the prospective Basel Study. Am J Epidemiol 1991; 133: 766-75.
Michaud DS, Feskanich D, Rimm EB, Colditz GA, Speizer FE, et al. Intake of specific carotenoids and risk of lung cancer in 2 prospective US cohorts. Am J Clin Nutr 2000; 72: 990-7.
Franceschi S, Bidoli E, La Vecchia C, Talamini R, D’Avanzo B, et al. Tomatoes and risk of digestive-tract cancers. Int J Cancer 1994; 59: 181-4. http://dx.doi.org/10.1002/ijc.2910590207
Di Mascio P, Kaiser S, Sies H. Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys 1989; 274: 532-8. http://dx.doi.org/10.1016/0003-9861(89)90467-0
Caltagirone S, Ranelletti FO, Rinelli A, Maggiano N, Colasante A, et al. Interaction with type II estrogen binding sites and antiproliferative activity of tamoxifen and quercetin in human non-small-cell lung cancer. Am J Respir Cell Mol Biol 1997; 17: 51-9.
Sharma RA, Gescher AJ, Steward WP. Curcumin: the story so far. Eur J Cancer2005; 41: 1955-68. http://dx.doi.org/10.1016/j.ejca.2005.05.009
Salonen JT, Salonen R, Lappetelainen R, Maenpaa PH, Alfthan G, et al. Risk of cancer in relation to serum concentrations of selenium and vitamins A and E: matched case-control analysis of prospective data. Br Med J 1985; 290: 417-20. http://dx.doi.org/10.1136/bmj.290.6466.417
Omenn GS. Micronutirents (vitamins and minerals) as cancer-preventive agents. IARC Sci Publ 1996; 139: 33-45.
Clark LC, Combs GF Jr, Turnbull BW, Slate EH, Chalker DK, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: a randomized controlled trial. Nutritional Prevention of Cancer Study. JAMA 1996; 276: 1957-63. http://dx.doi.org/10.1001/jama.1996.03540240035027
National Research Council Staff. Diet and Health: Implications for Reducing Chronic Disease Risk. Washington, DC: National Academy of Education 1989; pp. 376-9.
Schrauzer G. The nutritional significance, metabolism and toxicology of selenomethionine. Adv Food Nutr Res 2003: 47: 73-112. http://dx.doi.org/10.1016/S1043-4526(03)47002-2
Mahabir S, Schendel K, Dong YQ, Barrera SL, Spitz MR, et al. Dietary alpha- beta- gamma and delta-tocopherols in lung cancer risk. Int J Cancer 2008; 123: 1173-80. http://dx.doi.org/10.1002/ijc.23649
Woodson K, Tangrea JA, Barrett MJ, Virtamo J, Taylor PR, et al. Serum alpha-tocopherol and subsequent risk of lung cancer among male smokers. J Natl Cancer Inst 1999; 91: 1738-43. http://dx.doi.org/10.1093/jnci/91.20.1738
Chen J, Geissler C, Parpia B, Li J, Campbell TC. Antioxidant status and cancer mortality in China. Int J Epidemiol 1992; 21: 625-5. http://dx.doi.org/10.1093/ije/21.4.625
Tisdale MJ. Cancer cachexia. Anticancer Drugs 1993; 4: 15-25. http://dx.doi.org/10.1097/00001813-199304000-00001
Wurtman RJ, Anton-Tay F. The mammalian pineal as a neuroendocrine transducer. Recent Prog Horm Res 1969; 25: 493-522
Lissoni P, Chilelli M, Villa S, Cerizza L, Tancini G. Five-years survival in metastatic non-small lung cancer patients treated with chemotherapy alone or chemotherapy and melatonin: a randomized trial. J Pineal Res 2003; 35: 12-15. http://dx.doi.org/10.1034/j.1600-079X.2003.00032.x
Cao Y, Cao R. Angiogenesis inhibited by drinking tea. Nature 1999; 398: 381. http://dx.doi.org/10.1038/18793
Laurie SA, Miller VA, Grant SC, Kris MG, Ng KK. Phase I study of green tea extract in patients with advanced lung cancer. Cancer Chemother Pharmacol 2005; 55: 33-8. http://dx.doi.org/10.1007/s00280-004-0859-1
Lee KW, Kim YJ, Lee HJ, Lee CY. Cocoa Has More Phenolic Phytochemicals and a Higher Antioxidant Capacity than Teas and Red Wine. J Agr Food Chem 2003; 51(25): 7292-7295. http://dx.doi.org/10.1021/jf0344385
Cross AJ, Leitzmann MF, Gail MH, Hollenbeck AR, Schatzkin A, Sinha R. A prospective study of red and processed meat intake in relation to cancer risk. PloS Med 2007; 4: e325. http://dx.doi.org/10.1371/journal.pmed.0040325
Wallace FA, Neely SJ, Miles EA, Calder PC. Dietary fats affect macrophage-mediated cytotoxicity towards tumour cells. Immunol Cell Biol 2000; 78: 40-8. http://dx.doi.org/10.1046/j.1440-1711.2000.00867.x
Roebuck BD. Dietary fat and the development of pancreatic cancer. Lipids 1992; 27: 804-6. http://dx.doi.org/10.1007/BF02535854
Rothkopf M. Fuel utilization in neoplastic disease: implications for the use of nutritional support in cancer patients. Nutr Supp 1990; 6: 14-16.
Collier B, Dossett LA, May AK, Diaz JJ. Glucose Control and the Inflammatory Response. Nutr Clin Pract2008;23: 3-15. http://dx.doi.org/10.1177/011542650802300103
McCulloch M, See C, Shu XJ, Broffman M, Kramer A, et al. Astragalus-based Chinese herbs and platinum-based chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials. J Clin Oncol 2006; 24: 419-30. http://dx.doi.org/10.1200/JCO.2005.03.6392
Taixiang W, Munro AJ, Guanjian L. Chinese medical herbs for chemotherapy side effects in colorectal cancer patients. Cochrane Database Syst Rev 2005; 1: CD4540.
Sadava D, Phillips T, Lin C, Kane SE. Transferrin overcomes drug resistance to artemisinin in human small cell lung carcinoma cells. Cancer Lett 2002; 179: 151-156. http://dx.doi.org/10.1016/S0304-3835(02)00005-8
Kwon, Phytochemical constituents of Artemisia stolonifera. Arch Pharm Res 2001; 24: 312-5. http://dx.doi.org/10.1007/BF02975098
Efferth T, Dunstan H, Sauerbrey A, Miyachi H, Chitambar CR. The anti-malarial artesunate is also active against cancer.Int J Oncol 2001; 18: 767-73.
Chipperfield B, Chipperfield J. Ubiquinone and nucleic acid concentrations in the heart muscle of cancer patients and normal controls. Clin Chim Acta1971; 31: 459-65. http://dx.doi.org/10.1016/0009-8981(71)90419-0
Weber C, Sejersgard-Jakobsen T, Mortensen SA, Paulsen G, Holmer G. Antioxidative effect of dietary coenzyme Q10 in human blood plasma. Int J Vit Nutr Res 1994; 64: 311-5.
Folkers K, Osterborg A, Nylander M, Morita M, Mellstedt H. Activities of vitamin Q10 in animal models and a serious deficiency in patients with cancer. Biochem Biophys Res Commun 1997; 234: 296-9. http://dx.doi.org/10.1006/bbrc.1997.6522
Jatoi A, Williams B, Nichols F, Marks R, Aubry MC, et al. Is voluntary vitamin and mineral supplementation associated with better outcome in non-small cell lung cancer patients? Results from the Mayo Clinic lung cancer cohort. Lung Cancer 2005; 49: 77-84. http://dx.doi.org/10.1016/j.lungcan.2005.01.004
Jatoi A, Daly BD, Kramer G, Mason JB. A cross-sectional study of vitamin intake in postoperative non-small cell lung cancer patients. J Surg Oncol 1998; 68: 231-6. http://dx.doi.org/10.1002/(SICI)1096-9098(199808)68:4<231::AID-JSO5>3.0.CO;2-5
Banerjee S, Li Y, Wang Z, Sarkar FH. Multi-targeted therapy of cancer by genistein. Cancer Lett 2008; 269: 226-42. http://dx.doi.org/10.1016/j.canlet.2008.03.052
Lian F, Li Y, Bhuiyan M, Sarkar FH. P53-independent apoptosis induced by genistein in lung cancer cells. Nutr Cancer 1999; 33: 125-31.http://dx.doi.org/10.1207/S15327914NC330202
Sarkar F, Li Y. Soy isoflavones and cancer prevention. Cancer Invest2003; 21: 744-57. http://dx.doi.org/10.1081/CNV-120023773
Vokes E, Herbst R, Sandler A. Angiogenesis inhibition in the treatment of lung cancer. Clin Adv Hematol Oncol 2006; 4: 1-10.
Nagabhushan M, Bhide S. Curcumin as an inhibitor of cancer. J Am Coll Nutr 1992; 11: 192-8.
Bengmark S. Curcumin, an atoxic antioxidant and natural NfkappaB, cyclooxygenase-2, lipooxygenase, and inducible nitric oxide synthase inhibitor: a shield against acute and chronic diseases. JPEN J Parenter Enteral Nutr 2006; 30: 45-51. http://dx.doi.org/10.1177/014860710603000145
Sen S, Sharma H, Singh N. Curcumin enhances Vinorelbine mediated apoptosis in NSCLC cells by the mitochondrial pathway. Biochem Biophys Res Commun 2005; 17; 331: 1245-52. http://dx.doi.org/10.1016/j.bbrc.2005.04.044
Yang JH, Hsia TC, Kuo HM, Chao PD, Chou CC, et al. Inhibition of lung cancer cell growth by quercetin glucuronides via G2/M arrest and induction of apoptosis. Drug Metab Dispos 2006; 34: 296-304. http://dx.doi.org/10.1124/dmd.105.005280
Liao HF, Kuo CD, Yang YC, Lin CP, Tai HC, et al. Resveratrol enhances radiosensitivity of human non-small cell lung cancer NCI-H838 cells accompanied by inhibition of nuclear factor-kappa B activation. J Radiat Res2005; 46: 387-93. http://dx.doi.org/10.1269/jrr.46.387
Cao Y, Fu ZD, Wang F, Liu HY, Han R. Anti-angiogenic activity of resveratrol, a natural compound from medicinal plants. J Asian Nat Prod Res 2005; 7: 205-13. http://dx.doi.org/10.1080/10286020410001690190
Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell2006; 127: 1109-22. http://dx.doi.org/10.1016/j.cell.2006.11.013
Folkman J. Tumor angiogenesis: therapeutic implications. N Eng J Med 1971; 285: 1182-86. http://dx.doi.org/10.1056/NEJM197111182852108
Lee A, Langer R. Shark cartilage contains inhibitors of tumor angiogenesis. Science 1983; 221: 1185-87. http://dx.doi.org/10.1126/science.6193581
Moses MA, Sudhalter J, Langer R. Identification of an Inhibitor of Neovascularization from Cartilage. Science 1990; 248: 1408-10. http://dx.doi.org/10.1126/science.1694043
Oikawa T, Ashino-Fuse H, Shimamura M, Koide U, Iwaguchi T. A novel angiogenic inhibitor derived from Japanese shark cartilage. Extraction and estimation of inhibitory activities toward tumor and embryonic angiogenesis. Cancer Lett 1990; 51: 181-5. http://dx.doi.org/10.1016/0304-3835(90)90100-C
Weidner N, Semple JP, Welch WR, Folkman J. Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma, N Eng J Med 1991; 324: 1-8. http://dx.doi.org/10.1056/NEJM199101033240101
Brem H, Folkman J. Inhibition of tumor angiogenesis mediated by cartilage. J Exp Med1975; 141: 427-39. http://dx.doi.org/10.1084/jem.141.2.427
Gingras D, Renaud A, Mousseau N, Beliveau R. Shark cartilage as antiangiogenic agent: smart dinks or bitter pills? Cancer Metastasis Rev 2000; 19: 83-6. http://dx.doi.org/10.1023/A:1026504500555
Krishnan AV, Trump DL, Johnson CS, Feldman D. The role of Vitamin D in cancer prevention and treatment. Endocrinol Metabol Clin N Am 2010; 39: 401-418. http://dx.doi.org/10.1016/j.ecl.2010.02.011
Murphy RA, Mourtzakis M, Chu QS, Baracos VE, Reiman T, Mazurak VC. Supplementation with fish oil increases first-line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer. Cancer 2011; 117: 3774-80. http://dx.doi.org/10.1002/cncr.25933
van der Meij BS, Langius JA, Spreeuwenberg MD, Slootmaker SM, Paul MA, et al. Oral nutritional supplements containing n-3 polyunsaturated fatty acids affect quality of life and functional status in lung cancer patients during multimodality treatment: an RCT. Eur J Clin Nutr 2012; 66: 399-404. http://dx.doi.org/10.1038/ejcn.2011.214
Hursting SD, Thornquist M, Henderson MM. Types of dietary fat and the incidence of cancer at five sites. Prev Med 1990; 19: 242-53. http://dx.doi.org/10.1016/0091-7435(90)90025-F
Argilés JM. Cancer-associated malnutrition. Eur J Oncol Nurs 2005; 9(Suppl 2): S39-50. http://dx.doi.org/10.1016/j.ejon.2005.09.006
Travis WD, Travis LB, Devesa S. Lung cancer. Cancer 1995; 75: 191-202. http://dx.doi.org/10.1002/1097-0142(19950101)75:1+<191::AID-CNCR2820751307>3.0.CO;2-Y
Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. Cancer statistics, 2009. CA Cancer J Clin2009; 59: 225-49. http://dx.doi.org/10.3322/caac.20006
Punturieri A, Szabo E, Croxton TL, Shapiro SD, Dubinett SM. Lung cancer and chronic obstructive pulmonary disease: needs and opportunities for integrated research. J Natl Cancer Inst 2009; 101: 554-9. http://dx.doi.org/10.1093/jnci/djp023
Hecht S. Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet Oncol2002; 3: 461-9. http://dx.doi.org/10.1016/S1470-2045(02)00815-X
Knaapen AM, Gungor N, Schins RP, Borm PJ, Van Schooten FJ. Neutrophils and respiratory tract DNA damage and mutagenesis: a review. Mutagenesis2006; 21: 225-36. http://dx.doi.org/10.1093/mutage/gel032
Rahman I, Biswas SK, Kode A. Oxidant and antioxidant balance in the airways and airway diseases. Eur J Pharmacol 2006; 533: 222-39. http://dx.doi.org/10.1016/j.ejphar.2005.12.087
Biesalski HK, Bueno de Mesquita B, Chesson A, Chytil F, Grimble R, et al. European Consensus Statement on Lung Cancer: risk factors and prevention. Lung Cancer Panel. CA Cancer J Clin 1998; 48: 167-76. http://dx.doi.org/10.3322/canjclin.48.3.167
Hecht S. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer 2003; 3: 733-44. http://dx.doi.org/10.1038/nrc1190
Alberg A, Nonemaker J. Who is at high risk for lung cancer? Population-level and individual-level perspectives. Semin Respir Crit Care Med 2008: 29: 223-32. http://dx.doi.org/10.1055/s-2008-1076742
Marquez-Garban DC, Mah V, Alavi M, Maresh EL, Chen HW, et al. Progesterone and estrogen receptor expression and activity in human non-small cell lung cancer. Steroids2011; 76: 910-20.
Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet2008; 371: 569-78. http://dx.doi.org/10.1016/S0140-6736(08)60269-X
Chan HP, Lewis C, Thomas PS.Oxidative stress and exhaled breath analysis: a promising tool for detection of lung cancer. Cancers 2010; 2: 32-42. http://dx.doi.org/10.3390/cancers2010032
Neuberger J, Field R. Occupation and lung cancer in nonsmokers. Rev Environ Health 2003; 18: 251-67. http://dx.doi.org/10.1515/REVEH.2003.18.4.251
Fong KM, Sekido Y, Gazdar AF, Minna JD. Molecular biology of lung cancer: clinical implications. BMJ(Thorax) 2003; 58: 892-900.
Hung RJ, Boffetta P, Brockmoller J, Butkiewicz D, Cascorbi I, et al. CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: a pooled analysis. Carcinogenesis 2003; 24: 875-82. http://dx.doi.org/10.1093/carcin/bgg026
Ng DP, Tan KW, Zhao B, Seow A. CYP1A1 polymorphisms and risk of lung cancer in non-smoking Chinese women: influence of environmental tobacco smoke exposure and GSTM1/T1 genetic variation. Cancer Causes Contr 2005; 16: 399-405. http://dx.doi.org/10.1007/s10552-004-5476-0
Gsur A, Haidinger G, Hollaus P, Herbacek I, Madersbacher S, et al. Genetic polymorpisms of CYP1A1 and GSTM1 and lung cancer risk. Anticancer Res 2001; 21: 2237-42.
Wenzlaff AS, Cote ML, Bock CH, Land SJ, Santer SK, et al. CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study. Carcinogenesis 2005; 26: 2207-12. http://dx.doi.org/10.1093/carcin/bgi191
Yang M, Choi Y, Hwangbo B, Lee JS. Combined effects of genetic polymorphisms in six selected genes on lung cancer susceptibility. Lung Cancer 2007; 57: 135-42. http://dx.doi.org/10.1016/j.lungcan.2007.03.005
Engels EA, Wu X, Gu J, Dong Q, Liu J, Spitz MR. Systematic evaluation of genetic variants in the inflammation pathway and risk of lung cancer. Cancer Res 2007; 67: 6520-27. http://dx.doi.org/10.1158/0008-5472.CAN-07-0370
Son JW, Kang HK, Chae MH, Choi JE, Park JM, et al. Polymorphisms in the caspase-8 gene and the risk of lung cancer. Cancer Genetics Cytogenetics 2006; 169: 121-27. http://dx.doi.org/10.1016/j.cancergencyto.2006.04.001
Yin J, Vogel U, Ma Y, Qi R, Sun Z, et al. DNA repair gene XRCC1 and genetic susceptibility of lung cancer in a northeastern Chinese population. Lung Cancer 2007; 56: 153-60. http://dx.doi.org/10.1016/j.lungcan.2006.12.012
Williams M, Sandler A. The epidemiology of lung cancer. Cancer Treat Res 2001; 105: 31-52. http://dx.doi.org/10.1007/978-1-4615-1589-0_2
Grant J. Proper use and recognized role of TPN in the cancer patient. Nutrition 1990; 6: 6s-7s.
Bauer J, Capra S. Nutrition intervention improves outcomes in patients with cancer cachexia receiving chemotherapy: a pilot study. Support Care Cancer 2005; 13: 270-4. http://dx.doi.org/10.1007/s00520-004-0746-7
McMahon K, Decker G, Ottery FD. Integrating proactive nutritional assessment in clinical practices to prevent complications and cost. Semin Oncol 1998; 25: 20-7.
Bruera E. ABC of palliative care. Anorexia, cachexia, and nutrition. BMJ 1997; 315: 1219-22. http://dx.doi.org/10.1136/bmj.315.7117.1219
Rivadeneira DE, Evoy D, Fahey TJ 3rd, Lieberman MD, Daly JM. Nutritional support of the cancer patient. CA Cancer J Clin 1998; 48: 69-80. http://dx.doi.org/10.3322/canjclin.48.2.69
American Cancer Society. Nutrition for the Person with Cancer: A Guide for Patients and Families. Atlanta, Ga: American Cancer Society, Inc., 2000.
Shils M. Nutrition and Diet in Cancer Management. In: Shils ME, Olson JA, Shike M, et al. Eds. Modern Nutrition in Health and Disease. 9th ed. Baltimore: Williams & Wilkins 1999; pp. 1317-47.
Laskin JJ, Sandler AB. First-line treatment for advanced non-small-cell lung cancer. Oncology 2005; 19: 1671-6.
Breathnach OS, Freidlin B, Coley B, Green MR, Johnson DH, et al. Twenty-two years of Phase III trials for patients with advanced non-small cell lung cancer: sobering results. J Clin Oncol 2001; 19: 1734-42.
Morgan G, Ward R, Barton M. The Contribution of Cytotoxic Chemotherapy to 5-year Survival in Adult Malignancies. Clin Onco 2004; 16: 549-60. http://dx.doi.org/10.1016/j.clon.2004.06.007
Croswell JM, Baker SG, Marcus PM, Clapp JD, Kramer BS. Cumulative incidence of false-positive test results in lung cancer screening: a randomized trial. AnnInternMed 2010; 152: 505-12.
Humphrey LL, Teutsch S, Johnson M. U.S. Preventive Services Task Force. Lung cancer screening with sputum cytologic examination, chest radiography, and computed tomography: an update for the U.S. Preventive Services Task Force. Ann Intern Med2004; 140: 740-53.
Chan HP, Lewis C, Thomas PS. Exhaled breath analysis: novel approach for early detection of lung cancer. Lung Cancer 2009; 63: 164-8. http://dx.doi.org/10.1016/j.lungcan.2008.05.020
Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne EA, et al. Increased nitric oxide in exhaled air of asthmatic patients. Lancet1994; 343: 133-5. http://dx.doi.org/10.1016/S0140-6736(94)90931-8
Liu J, Sandrini A, Thurston MC, Yates DH, Thomas PS. Nitric oxide and exhaled breath nitrite/nitrates in chronic obstructive pulmonary disease patients. Respiration2007; 74: 617-23. http://dx.doi.org/10.1159/000106379
Horvath I, Lazar Z, Gyulai N, Kollai M, Losonczy G. Exhaled biomarkers in lung cancer. Eur RespirJ 2009; 34: 261-75. http://dx.doi.org/10.1183/09031936.00142508
Vachani A, Nana-Sinkam P. Searching for the elusive biomarker in lung cancer. Where should we look? Cancer Biol Ther 2010; 10: 273-5. http://dx.doi.org/10.4161/cbt.10.3.12695
NSCLC Meta-Analyses Collaborative Group. Chemotherapy in Addition to Supportive Care Improves Survival in Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data From 16 Randomized Controlled Trials. J Clin Oncol 2008; 26: 4617-25. http://dx.doi.org/10.1200/JCO.2008.17.7162
Salgia R, Harpole D, Herndon JE 2nd, Pisick E, Elias A, Skarin AT. Role of serum tumor markers CA 125 and CEA in non-small cell lung cancer. Anticancer Res 2001; 21: 1241-6.
McWilliams A, Lam B, Sutedja T. Early proximal lung cancer diagnosis and treatment. Eur Respir J 2009; 33: 656-65.http://dx.doi.org/10.1183/09031936.00124608
Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc 2008; 83: 584-94.
National Cancer Institute. Nutrition in Cancer Care. http://www.cancer.gov/cancertopics/pdq/supportivecare/nutrition. Accessed: 19 September, 2012.
Langstein H, Norton J. Mechanisms of cancer cachexia. Hematol Oncol Clin North Am 1991; 5: 103-23.
Policy for Journals/Articles with Open Access
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work
Policy for Journals / Manuscript with Paid Access
Authors who publish with this journal agree to the following terms:
- Publisher retain copyright .
- Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work .